Published in J Pediatr Gastroenterol Nutr on June 01, 2013
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases (GMT) | NCT01560819
Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (FMT) | NCT02496390
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) | NCT02516384
Pediatric FEcal Microbial Transplant for Ulcerative Colitis (PediFETCh) | NCT02487238
PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (PediCRaFT) | NCT03378167
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96
Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clin Gastroenterol Hepatol (2013) 1.64
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep (2013) 1.30
From stool transplants to next-generation microbiota therapeutics. Gastroenterology (2014) 1.29
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol (2014) 1.17
Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis (2015) 1.09
Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep (2015) 1.03
The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2014) 1.01
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.99
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol (2015) 0.97
Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol (2015) 0.96
Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med (2015) 0.94
Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis. Am J Gastroenterol (2015) 0.93
Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol (2014) 0.92
Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS One (2015) 0.91
Why is initial bacterial colonization of the intestine important to infants' and children's health? J Pediatr Gastroenterol Nutr (2015) 0.90
Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol (2015) 0.89
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) (2014) 0.89
Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol (2014) 0.88
Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One (2016) 0.87
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol (2014) 0.87
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome (2017) 0.85
Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol (2014) 0.85
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol (2014) 0.85
Bugging inflammation: role of the gut microbiota. Clin Transl Immunology (2016) 0.84
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. J Gastroenterol (2016) 0.84
Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.82
Management of ulcerative colitis. Arch Dis Child (2015) 0.80
Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes (2016) 0.79
The environment within: exploring the role of the gut microbiome in health and disease. Environ Health Perspect (2013) 0.79
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches. Curr Treat Options Gastroenterol (2015) 0.79
Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders. World J Gastrointest Pathophysiol (2013) 0.79
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.79
Probiotic use in horses - what is the evidence for their clinical efficacy? J Vet Intern Med (2014) 0.79
Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome (2017) 0.78
Current stage in inflammatory bowel disease: What is next? World J Gastroenterol (2015) 0.78
Failure of Fecal Microbiota Transplantation in a Three-Year-Old Child with Severe Refractory Ulcerative Colitis. Pediatr Gastroenterol Hepatol Nutr (2016) 0.78
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol (2016) 0.77
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis. PLoS One (2016) 0.77
Fecal microbial therapy: promises and pitfalls. J Pediatr Gastroenterol Nutr (2014) 0.77
Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol (2017) 0.77
Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.76
Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.76
Fecal Microbiota Transplantation for Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2016) 0.76
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail. Mucosal Immunol (2016) 0.76
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci (2017) 0.76
The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res (2017) 0.75
Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future. F1000Res (2016) 0.75
Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol (2015) 0.75
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial. Middle East J Dig Dis (2015) 0.75
Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol (2016) 0.75
Medical stool: the future of treatment for inflammatory bowel disease? J Pediatr Gastroenterol Nutr (2013) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
The Microbiome and Sustainable Healthcare. Healthcare (Basel) (2015) 0.75
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75
Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going? SAGE Open Med (2017) 0.75
Indoles from commensal bacteria extend healthspan. Proc Natl Acad Sci U S A (2017) 0.75
Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife (2017) 0.75
Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2017) 0.75
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology (2006) 3.32
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet (2009) 3.19
Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis (2004) 2.52
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2014) 2.39
Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol (2008) 2.09
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr (2005) 1.98
Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet (2010) 1.81
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.77
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74
Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol (2011) 1.60
IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis (2013) 1.59
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis (2005) 1.55
Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.49
Pancreatitis in children. J Pediatr Gastroenterol Nutr (2003) 1.44
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease. Inflamm Bowel Dis (2010) 1.42
The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol (2006) 1.33
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol (2006) 1.33
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology (2010) 1.32
Improved risk prediction for Crohn's disease with a multi-locus approach. Hum Mol Genet (2011) 1.28
Multidimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn's disease. Inflamm Bowel Dis (2013) 1.18
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18
Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis (2007) 1.17
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis (2008) 1.17
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr (2009) 1.15
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis (2009) 1.13
Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm Bowel Dis (2010) 1.11
CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Inflamm Bowel Dis (2008) 1.11
Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics (2007) 1.10
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease. Am J Gastroenterol (2009) 1.07
Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.06
Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflamm Bowel Dis (2007) 1.05
Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis (2009) 1.03
Crohn's disease and genetic hitchhiking at IBD5. Mol Biol Evol (2011) 1.03
Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Gastroenterol Clin North Am (2009) 1.02
Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study. Ann Hum Genet (2010) 1.01
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis (2007) 1.01
Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol (2010) 1.00
Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.00
Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. Clin Gastroenterol Hepatol (2011) 1.00
Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 0.98
Inflammatory bowel disease. Adolesc Med Clin (2004) 0.98
Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet (2006) 0.98
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis (2009) 0.97
The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology (2012) 0.97
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda. Inflamm Bowel Dis (2013) 0.97
Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 0.92
Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis (2013) 0.91
DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Am J Gastroenterol (2006) 0.91
Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol (2007) 0.91
Natalizumab therapy for moderate to severe Crohn disease in adolescents. J Pediatr Gastroenterol Nutr (2007) 0.91
Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol (2006) 0.90
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol (2008) 0.90
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88
Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics (2005) 0.88
Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm Bowel Dis (2009) 0.87
Medical radiation exposure in children with inflammatory bowel disease estimates high cumulative doses. Inflamm Bowel Dis (2011) 0.87
Inflammatory bowel disease in children: current trends. J Gastroenterol (2010) 0.87
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr (2010) 0.86
Comparison of magnetic resonance enterography with endoscopy, histopathology, and laboratory evaluation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2012) 0.85
Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med Clin North Am (2010) 0.85
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis (2014) 0.84
Vitamin D status and bone mineral density in African American children with Crohn disease. J Pediatr Gastroenterol Nutr (2013) 0.83
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH. J Pediatr Gastroenterol Nutr (2009) 0.81
Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studies. Gastroenterology (2008) 0.81
Vertebral osteomyelitis due to Candida parapsilosis in a child with Crohn disease while receiving anti-TNF therapy. J Pediatr Gastroenterol Nutr (2013) 0.81
Genetic determinants of pediatric inflammatory bowel disease: is age of onset genetically determined? Dig Dis (2009) 0.80
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension. Curr Med Res Opin (2011) 0.80
Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. J Pediatr (2011) 0.79
Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture. Inflamm Bowel Dis (2012) 0.79
Markers that differentiate early from late IBD. Dig Dis (2012) 0.78
Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.78
Ureteropelvic junction obstruction: an overlooked cause of cyclic vomiting. Am J Gastroenterol (2002) 0.78
Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? Dig Dis (2013) 0.78
Rising incidence of inflammatory bowel disease in young children: What does the future hold? J Pediatr Gastroenterol Nutr (2011) 0.77
Brief report: development of the inflammatory bowel disease family responsibility questionnaire. J Pediatr Psychol (2009) 0.77
The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study. Cancer Manag Res (2012) 0.77
Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2015) 0.77
Functional genomics and its implications for molecular medicine. Pediatr Clin North Am (2006) 0.76
Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr (2016) 0.76
Use of Reticulocyte Hemoglobin Content in the Assessment of Iron Deficiency in Children with Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr (2016) 0.75
A practical and novel method to extract genomic DNA from blood collection kits for plasma protein preservation. J Vis Exp (2013) 0.75
Commentaries on "Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada": pediatric inflammatory bowel disease networks: raising the bar. J Pediatr Gastroenterol Nutr (2012) 0.75
What are the risk factors for surgery and their implications for management of children with Crohn's disease? Nat Clin Pract Gastroenterol Hepatol (2006) 0.75
Hidradenitis suppurativa and pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2015) 0.75
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis. Am J Surg Pathol (2017) 0.75
Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience. Inflamm Bowel Dis (2017) 0.75
Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. Am J Gastroenterol (2006) 0.75
Biological motion processing under interocular suppression. J Vis (2015) 0.75
Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe. Inflamm Bowel Dis (2017) 0.75
Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2015) 0.75
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
O-009 Long ncRNA Landscape in the Ileum of Treatment Naïve Early Onset Crohn Disease. Inflamm Bowel Dis (2017) 0.75
PUFAs and IBD: Is There a Relationship? Inflamm Bowel Dis (2017) 0.75
Familial Association of Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies in Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr (2017) 0.75
Infliximab Optimization Based on Therapeutic Drug Monitoring in Pediatric IBD. J Pediatr Gastroenterol Nutr (2016) 0.75
Magnetic Resonance Enterography Healing and Magnetic Resonance Enterography Remission Predicts Improved Outcome in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr (2016) 0.75